Post by Merck Healthcare

Today, we announce that Miguel Fernández Alcalde has been appointed Head of Global Commercial Strategy for Merck Healthcare. Monia Vial is appointed as President of EMD Serono, Head of North America. “Miguel has consistently demonstrated the vision, agility, and commitment to patients that this role demands, across geographies, business functions, and every level of leadership. He is exceptionally well positioned to shape our global commercial strategy for the future" said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck KGaA, Darmstadt, Germany. “Looking ahead, Monia brings to our company deep leadership experience in the United States, along with invaluable international perspective and cultural fluency. Over the last eight years, she has built a rare disease franchise from the ground up, delivering outstanding results across multiple brands, indications, and product launches.” Andrew Paterson has made the decision to retire after a successful career spanning over 31 years in the company. Please join us in thanking Andrew for his leadership, and in congratulating Miguel and Monia on their upcoming appointments. Click here to read the full announcement: https://lnkd.in/eMTgi3eB

Video Content